Previous Article | Next Article ![]()
Infection and Immunity, July 2002, p. 3874-3880, Vol. 70, No. 7
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.7.3874-3880.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia,1 Institute of Medical Microbiology, Technical University, Munich, Germany2
Received 30 November 2001/ Returned for modification 30 January 2002/ Accepted 2 April 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Dendritic cells (DCs) are sentinels that have the ability to detect pathogens, induce T-cell activation, and trigger memory T cells, providing a link between the innate and adaptive immune systems (5, 6, 24). In turn, pathogens have evolved mechanisms to exploit or evade DC biology (24). Not surprisingly, there is evidence that in leishmaniasis, DCs are involved in the initiation and maintenance of T-cell immune responses. However, their precise role in the development and regulation of Th1 or Th2 responses is not known.
A large volume of data has accumulated which shows that DCs are phenotypically and functionally heterogeneous (20). In the mouse spleen three distinct subpopulations of DCs have been identified (27), whereas in skin-draining lymph nodes we recently showed the existence of five subpopulations (14). There is evidence that the three spleen subpopulations are products of separate developmental lineages, have different life spans (17), and, most importantly, may be functionally distinct. Indeed, each of these subsets secretes a different pattern of cytokines (15). Although several studies have shown that L. major or Leishmania mexicana amastigotes can infect cultured skin-derived or bone marrow-derived DCs (7, 10, 25, 26), there has been no characterization of the host cell phenotype. Here, we explore the interactions of the parasite with purified splenic DC subpopulations and show that there are significant differences in response to infection. In macrophages, the phagocytosed parasites reside in a parasite-modified lysosome, the parasitophorous vacuole (PV), with hierarchically restricted access to the extracellular environment. This location is significant in terms of parasite survival, as well as in terms of the ability of the cells to present parasite antigen to T cells (4). In this study we examined for the first time the L. major PV in infected DCs and found that the parasites reside in a lysosome-associated membrane protein 1 (Lamp1)- and major histocompatibility complex (MHC) class II-positive compartment, similar to the situation in macrophages. However, compared to the number of parasites per macrophage, the number of parasites per DC is much lower.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Parasites. The L. major isolate LRC-L137 (MHOM/IL/67/JerichoII) was obtained from the World Health Organization Reference Center for Leishmaniasis, Jerusalem, Israel, and the virulent cloned line V121 isolated from this stock has been described before (13). Amastigotes were harvested from 4-week-old lesions at the base of the tail of CBA/H nu/nu mice and purified as described by Glaser et al. (11).
Isolation of DCs. DCs were isolated as described previously (27). Briefly, spleens were cut into small fragments, digested in RMPI 1640 medium supplemented with 10% fetal bovine serum (FBS) and containing collagenase (1 mg/ml; type II; Worthington Biochemical, Freehold, N.J.) and DNase (Boehringer, Mannheim, Germany), and then treated for 5 min with EDTA to disrupt T-cell-DC complexes. All subsequent procedures were performed at 0 to 4°C in a Ca2+- and Mg2+-free medium. Low-density cells (<1.077g/cm3 at mouse osmolarity at 4°C) were selected by centrifugation in a Nycodenz medium. Cells that were not of the DC lineage were then depleted by incubating the cells with previously optimized amounts of anti-CD3 (KT3), anti-Thy1 (T24/31.7), anti-B220 (RA3-6B2), anti-Gr-1 (RB6-8C5), and anti-erythrocyte (TER-119) and then removing the antibody-binding cells with anti-rat immunoglobulin-coupled magnetic beads (Dynabeads; Dynal, Oslo, Norway). The preparation was then used directly for immunofluorescence labeling prior to positive sorting by flow cytometry. The cell viability was more than 95% after purification.
Immunofluorescence labeling of DCs and isolation by flow cytometry.
The monoclonal antibodies, the fluorescent conjugates, and the multicolor labeling procedures used have all been described previously (27). To identify and sort all DCs, the pan-DC markers used were high levels of MHC class II or CD11c. Anti-MHC class II (M5/114) and anti-CD11c (N418) were used as fluorescein isothiocyanate (FITC) conjugates, anti-CD4 (GK1.5) was used as a phycoerythrin conjugate, and anti-CD8
(YTS169.4) was used as a Cy5 conjugate. Sorting was performed with a Moflo instrument (Cytomation Inc.). Gating on propidium iodide-labeled cells allowed exclusion of dead cells and autofluorescent cells.
Infection of DCs. After sorting, DC subpopulations were suspended in RPMI 1640 medium at a concentration of 106 cells/ml, and 100 µl was added to each well of 96-well plates. Amastigotes at a ratio of 10:1 were added to the wells, and the plates were incubated overnight. The cells were washed three times in EDTA-balanced salt solution supplemented with 10% FBS. After suspension at a concentration of 106 cells/ml in medium, the cells were placed on coverslips coated with anti-MHC class II antibodies and incubated for 1 to 2 h at 37°C in 10% CO2 in order to promote adherence to glass and spreading. The cells were washed three times in warm phosphate-buffered saline (PBS); then they were fixed with methanol and stained with Wright-Giemsa stain or fixed with 4% paraformaldehyde and stained for immunofluorescence as described below.
Infection of macrophages. To identify and sort peritoneal macrophages, the marker used was high-level expression of the surface marker F4/80. Peritoneal cells were washed and stained with FITC-conjugated anti-F4/80. After sorting and suspension in RPMI 1640 medium supplemented with FBS, cells were plated onto sterile coverslips in 24-well plates. Then 105 macrophages were seeded onto each coverslip and allowed to adhere for 1 to 2 h at 37°C in 5% CO2. V121 amastigotes were added to macrophage monolayers at a ratio of 10:1 and incubated overnight. The cells were washed twice in warm PBS, fixed with methanol, and stained with Wright-Giemsa stain. The infection rate and number of parasites per cell were estimated by counting at least 200 cells in duplicate samples.
Stimulation of isolated DCs for cytokine production.
Sorted splenic DCs (1 x 105 to 2 x 105 cells) were cultured in 200 µl of modified RPMI 1640 medium containing 10% FBS in 96-well round-bottom plates at 37°C in an atmosphere containing 10% CO2 in air. For interleukin-12 (IL-12) production, the stimulation mixture consisted of cytokines, microbial stimulus, or freshly purified L. major amastigotes. The cytokines used were granulocyte-macrophage colony-stimulating factor (200 U/ml), gamma interferon (IFN-
) (20 ng/ml), and IL-4 (100 U/ml), as indicated below (see Fig. 4). The other stimuli used were CpG-phosphorothioate (0.5 mM) and L. major amastigotes (parasite-to-cell ratio, 10:1). The supernatants were collected after 24 h. For IFN-
production the stimuli used were IL-12, IL-18 (1 ng/ml), and L. major amastigotes (parasite-to-cell ratio, 10:1) (see Fig. 5). The supernatants were collected after 72 h.
|
|
by ELISA.
The production of cytokines in the DC culture supernatants was determined by a capture enzyme-linked immunosorbent assay (ELISA). Briefly, 96-well polyvinyl chloride microtiter plates (Dynatech Laboratories, Chantilly, Va.) were coated with appropriate purified capture monoclonal antibodies, including R2-9A5 (anti-IL-12p70; hybridoma obtained from the American Type Culture Collection, Manassas, Va.), C15.6 (anti-IL-12p40; PharMingen), and RA-6A4 (anti-IFN-
; American Type Culture Collection). Cytokine binding was then detected with appropriate biotinylated detection monoclonal antibodies, including C17.8 (anti-IL-12 p40 and p70; hybridoma provided by L. Schofield, The Walter and Eliza Hall Institute) and XMG1.2 (anti-IFN-
; American Type Culture Collection). Binding of the second antibody was detected with streptavidin-horseradish peroxidase (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom), followed by a substrate solution containing 548 mg of 2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) (Sigma-Aldrich) per ml and 0.001% hydrogen peroxide (Ajax Chemicals, Aubern, Australia) in 0.1 M citric acid (pH 4.2). The optical densities at 405 to 490 nm of the samples were determined with an ELISA plate reader. Detection of NO. Nitric oxide (NO) production by DCs stimulated with the preparations described above was determined by assaying the stable end product NO2- using the Griess reaction. Portions (100 µl) of 48-h culture supernatants were each incubated with 100 µl of Griess reagent (0.05% nephthylethylenediamine, 0.5% sulfanilimide, 2.5% H3PO4) at room temperature for 10 min. The color reaction was read with an ELISA plate reader at 490 to 650 nm. Concentrations of NO in the samples were calibrated with a sodium nitrite reference standard.
Immunofluorescence and confocal laser microscopy. After fixation in paraformaldehyde, cells were washed and incubated with 0.05% saponine-PBS to allow permeabilization. The following antibodies used for immunofluorescence were diluted with 0.05% saponine-10% normal goat serum-PBS: anti-MHC class II (biotin-conjugated N22), anti-Lamp1 (Pharmingen), anti-cystatin C, and anti-Leishmania lipophosphoglycan (WIC79-3-FITC). For detection, streptavidin-Texas Red-, streptavidin-FITC-, or Texas Red-conjugated anti-rabbit and anti-rat immunoglobulin G preparations (Jackson ImmunoResearch) were used. The stained cells were visualized by confocal laser microscopy after they were mounted in the DAKO fluorescence mounting medium supplemented with diazabicyclo-2,2,2-octane (Sigma Chemical Co.)
Electron microscopy. L. major-infected DCs were pelleted and fixed overnight at 4°C in 2% paraformaldehyde-2% glutaraldehyde in PBS. Cells were washed five times in PBS, embedded in 2% agarose, and postfixed in 1% osmium tetroxide for 1 h at room temperature. Agar blocks were washed overnight in water and dehydrated in a graded acetone series (10 to 100%) before they were embedded in Spurr's resin. The sections were stained with lead citrate for examination by transmission electron microscopy.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
The presence of MHC class II molecules and cystatin C in the compartment which harbors the parasites, in combination with increased synthesis of MHC class II, suggests but does not prove that the infected DCs may be able to process and present parasite antigen to naïve T cells.
Comparison of parasite uptake by splenic DCs and macrophages. The uptake of amastigotes by freshly purified splenic DCs is not as efficient as the uptake of parasites by macrophages. We compared the parasite uptake by splenic DCs and resident peritoneal macrophages or the J774 macrophage cell line. We found that only 25 to 40% of splenic DCs harbored parasites, whereas more than 85% of the macrophages were infected under the same conditions. Not only was a higher percentage of macrophages infected, but each cell engulfed a significantly higher number of parasites. Indeed, while each splenic DC harbored, on average, 1 to 2 parasites, each peritoneal macrophage harbored more than 10 parasites after overnight culture. This suggests that the macrophage may be the preferential target cell for parasites, and it certainly is the most abundant cell in infected tissues. Since the DC life span is relatively short (17), it is unlikely that parasites spend sufficient time in infected DCs to be able to replicate, unless infection suppresses cell death and prolongs the DC life span (22). It is possible that residence in a DC leads to a state of parasite latency and promotes the development of the persistent or quiescent parasite known to survive in an immune individual in the presence of a strong protective immune response (1).
In terms of the ability of infected DCs to initiate T-cell responses, it is not known what the optimal time of pathogen residence or survival in a DC is for activation and subsequent interaction with T cells or other cells.
DC subpopulations show different susceptibilities to infection with L. major amastigotes.
Mouse splenic DCs are heterogeneous, as determined by the expression of CD4 and CD8
molecules on their surfaces. The three subpopulations of splenic DCs showed similar mature but unactivated phenotypes, as determined by expression of MHC class II, CD40, CD80, and CD86 markers (17). Despite this phenotype, in vivo and in vitro studies of the phagocytic capacities of these subpopulations performed with latex beads showed that a high proportion of all three populations (CD4+ CD8-, CD4- CD8+, and CD4- CD8-) had the capacity to take up latex beads, and the CD4- CD8+ population showed the lowest proportion of phagocytic cells (17).
The uptake of L. major parasites by splenic DCs has been addressed only once previously, in a study performed with total splenic DCs and promastigotes, the developmental form which is present in the sandfly and which initiates infection in the mammalian host. Here, the uptake of L. major amastigotes, the developmental form that is present in the mammalian host and is responsible for the disease, by the three splenic DC subsets was investigated. The splenic DC subsets, CD4+ CD8-, CD4- CD8-, CD4- CD8+, were purified from naïve C57BL/6 mice and incubated with freshly purified L. major amastigotes at a parasite-to-cell ratio of 10:1. After overnight culture, the cells were washed to remove free parasites, incubated on coverslips coated with anti-MHC class II antibody, and stained with Giemsa stain. Amastigote uptake was determined by microscopic examination of at least 200 cells. As shown in Fig. 2, of the three populations, the CD4+ CD8- DCs showed the greatest uptake of amastigotes, followed by the CD4- CD8- DCs, which were significantly (P < 0.05) less infected; the CD4- CD8+ DCs showed the lowest level of parasite uptake, and the value was significantly different from the values obtained for CD4+ CD8- DCs (P < 0.0001) and CD4- CD8- DCs (P < 0.0005). This hierarchy of susceptibility was not due to differences in the degrees of maturation of the three populations, which were similar as determined by expression of MHC class II, CD40, CD80, and CD86 (data not shown). New data are starting to shed light on mechanisms by which some mature DCs in lymphoid organs maintain the ability to capture and process antigen (9). The observation that splenic DC subpopulations display a hierarchy of susceptibility to infection may also apply to DCs in the skin-draining lymph nodes, which contain a similar complement of DCs and which may be important in cutaneous leishmaniasis (14).
|
As shown in Fig. 3, peritoneal macrophages, which have an infection rate of more than 85% after overnight culture, also express the highest level of CD11b at the surface. In contrast, CD4+ CD8- DCs, which have an infection rate of about 50%, and CD4- CD8- DCs, which have an infection rate of about 40%, express 10 times less CD11b on their surfaces. CD4- CD8+ DCs, which have the lowest infection rate (about 15%), do not express detectable CD11b on their surfaces, suggesting that CD11b could be at least one of the major receptors on DCs for the L. major amastigotes. Inhibition of invasion by F(ab)2 fragments of a receptor-blocking antibody, such as 5C6, should elucidate the role of this receptor. In addition, the roles of molecules such as the mannose-fucose receptor and CR1 need to be examined.
|
Effect of infection on cytokines and NO production by DCs.
Recent work has shown that differential expression of CD4 and CD8 molecules correlated with major differences in the capacities of DC subpopulations to produce cytokines (15). In intracellular infections such as leishmaniasis, resistance to disease correlates with induction of a polarized Th1 immune response. As IL-12 and IFN-
are major players in the induction of Th1 responses, production of these cytokines by infected DCs was examined.
In the presence of amastigotes, the CD4- CD8+ DC subset showed an increase in IL-12 production (Fig. 4). However, the IL-12 production by amastigote-infected DCs was low compared to that induced by strong stimuli, such as CpG, IFN-
, and IL-4 (15), and addition of amastigotes to a cocktail of CpG, IL-4, and IFN-
had no effect on the level of IL-12p70 or IL-12p40 (data not shown). However, amastigotes increased the amount of IL-12p40 produced by the CD4- CD8+ subpopulation. As this DC population is also the population which produces more bioactive p70, it probably keeps the ratio of p70 to p40 constant. It may be significant that the CD4- CD8+ DCs are the DCs that are infected least by Leishmania amastigotes.
In the presence of amastigotes alone, none of the splenic DC subsets could produce IFN-
(Fig. 5). However, when DCs were stimulated with IL-12 plus IL-18, we observed strong IFN-
production which was slightly upregulated in the presence of amastigotes, suggesting that there was positive feedback due to IL-12 production by these cells. This upregulation was more apparent in the CD4- CD8+ DCs, which are the best producers of IL-12.
NO is an important toxic effector molecule in the regulation of host defense and immunity and has been shown to be produced by bone marrow-derived DCs upon IFN-
and endotoxin stimulation (21). Moreover, NO production is considered the major effector mechanism leading to the intracellular killing of L. major in infected macrophages (19). Under our experimental conditions, no NO production was detected in any of the different DC subsets in the presence of L. major amastigotes and/or other stimuli, such as IFN-
, TNF-
, or CpG (data not shown).
Concluding remarks. A key feature of the immune responses induced by various microbial infections is plasticity in both the type and the magnitude of the response to individual organisms (16). Interaction between phenotypically and functionally heterogeneous antigen-presenting DCs and naïve T cells in the spleen and lymph nodes shapes the type and magnitude of this response. In leishmaniasis, this interaction may determine the disease manifestations depending on whether it leads to differentiation of a host-protective Th1 or a disease-exacerbating Th2 type of T cell. The studies presented here suggest that the microbe may influence the type of DCs that the naïve T cells interact with in the T-cell-rich area of the spleen and possibly the skin-draining lymph nodes. Thus, the intracellular amastigotes of Leishmania preferentially infect the CD4+ CD8- DC subpopulation and not the CD4- CD8+ cells best able to produce the proinflammatory cytokine IL-12 involved in the host-protective Th1 responses (Table 1). In addition, we found that the parasite is localized to an intracellular compartment containing Lamp1, MHC class II, and cystatin C, suggesting that the infected DCs should be able to present parasite antigen to T cells. The immunological consequences of the parasites' interactions with the specific DC populations is the subject of current work. In addition, in current experiments we aim to examine the interactions of amastigotes with DC subpopulations in vivo during the course of L. major infections in genetically resistant and susceptible mice which display polarized Th1 or Th2 immune responses.
|
| ACKNOWLEDGMENTS |
|---|
This work was supported by the National Health and Medical Research Council of Australia and by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220-226. |
| 2. | Alexander, J., and D. G. Russell. 1992. The interaction of Leishmania species with macrophages. Adv. Parasitol. 31:175-254.[Medline] |
| 3. | Alexander, J., A. R. Satoskar, and D. G. Russell. 1999. Leishmania species: models of intracellular parasitism. J. Cell Sci. 112:2993-3002.[Abstract] |
| 4. | Antoine, J. C., E. Prina, T. Lang, and N. Courret. 1998. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol. 6:392-401.[CrossRef][Medline] |
| 5. | Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.[CrossRef][Medline] |
| 6. | Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.[CrossRef][Medline] |
| 7. | Bennett, C. L., A. Misslitz, L. Colledge, T. Aebischer, and C. C. Blackburn. 2001. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol. 31:876-883.[CrossRef][Medline] |
| 8. | Blank, C., H. Fuchs, K. Rappersberger, M. Rollinghoff, and H. Moll. 1993. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J. Infect. Dis. 167:418-425.[Medline] |
| 9. | Bouchon, A., C. Hernandez-Munain, M. Cella, and M. Colonna. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111-1122. |
| 10. | Flohe, S., T. Lang, and H. Moll. 1997. Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major. Infect. Immun. 65:3444-3450.[Abstract] |
| 11. | Glaser, T. A., S. J. Wells, T. W. Spithill, J. M. Pettitt, D. C. Humphris, and A. J. Mukkada. 1990. Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp. Parasitol. 71:343-345.[CrossRef][Medline] |
| 12. | Handman, E. 1999. Cell biology of Leishmania. Adv. Parasitol. 44:1-39.[Medline] |
| 13. | Handman, E., R. E. Hocking, G. F. Mitchell, and T. W. Spithill. 1983. Isolation and characterization of infective and non-infective clones of Leishmania tropica. Mol. Biochem. Parasitol. 7:111-126.[CrossRef][Medline] |
| 14. | Henri, S., D. Vremec, A. Kamath, J. Waithman, S. Williams, C. Benoist, K. Burnham, S. Saeland, E. Handman, and K. Shortman. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:741-748. |
| 15. | Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J. Immunol. 166:5448-5455. |
| 16. | Jankovic, D., Z. Liu, and W. C. Gause. 2001. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 22:450-457.[CrossRef][Medline] |
| 17. | Kamath, A. T., J. Pooley, M. A. O'Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A. D'Amico, L. Wu, D. F. Tough, and K. Shortman. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:6762-6770. |
| 18. | Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Schlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:1063-1067. |
| 19. | Liew, F. Y., X. Q. Wei, and L. Proudfoot. 1997. Cytokines and nitric oxide as effector molecules against parasitic infections. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352:1311-1315.[CrossRef][Medline] |
| 20. | Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-262.[CrossRef][Medline] |
| 21. | Lu, L., C. A. Bonham, F. G. Chambers, S. C. Watkins, R. A. Hoffman, R. L. Simmons, and A. W. Thomson. 1996. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol. 157:3577-3586.[Abstract] |
| 22. | Moore, K. J., and G. Matlashewski. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:2930-2937.[Abstract] |
| 23. | Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.[CrossRef][Medline] |
| 24. | Rescigno, M., and P. Borrow. 2001. The host-pathogen interaction: new themes from dendritic cell biology. Cell 106:267-270.[CrossRef][Medline] |
| 25. | von Stebut, E., Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547-1552. |
| 26. | von Stebut, E., Y. Belkaid, B. V. Nguyen, M. Cushing, D. L. Sacks, and M. C. Udey. 2000. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis. Eur. J. Immunol. 30:3498-3506.[CrossRef][Medline] |
| 27. | Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978-2986. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|